Current treatment paradigms for locally advanced non-small cell lung cancer.

Current treatment paradigms for locally advanced non-small cell lung cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Current treatment paradigms for locally advanced non-small cell lung cancer. Abstract Text:

Locally advanced non-small cell lung cancer (NSCLC) is a multifaceted disease that is challenging to manage. The majority of patients can be appropriately treated with a combination of chemotherapy and radiation therapy; however, a subset of stage III patients who are considered surgical candidates may require a modification of this plan. For example, a trimodal approach using chemoradiation followed by surgery may be beneficial for fit patients with bulky mediastinal disease who are candidates for lobectomy, whereas patients with minimal mediastinal nodal involvement may receive only chemotherapy before surgical resection. No standard chemotherapy exists for this group of stage IIIA resectable patients. Phase II data from studies employing neoadjuvant cisplatin combinations suggest that these regimens are active and well tolerated. For patients with unresectable stage III NSCLC, concurrent chemoradiation is the standard of care at the present time for patients with good performance status, good pulmonary function tests, and an acceptable volume of normal lung receiving 20 Gy (V20). To manage distant micrometastasis further, induction and consolidation regimens are under investigation during which full-dose chemotherapy is administered either before (as induction) or after (as consolidation) concurrent chemoradiotherapy. To date, consolidation docetaxel after concurrent etoposide, cisplatin and thoracic radiation has shown encouraging survival results in a large Southwest Oncology Group phase II trial. This article will review the current treatment strategies for stage III NSCLC.

Current treatment paradigms for locally advanced non-small cell lung cancer. Publishing Authors By Initials

For similar diagnosis: diagnostic techniques and procedures: neoplasm staging research abstracts see: diagnosis: diagnostic techniques and procedures: neoplasm staging research

PUBMED ID PMID:

MEDLINE DATE:

Current treatment paradigms for locally advanced non-small cell lung cancer. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of thoracic oncology : official publicatio

VOLUME: 2 Suppl 2

Page Numbers: S77-85

Journal Abbreviation: J Thorac Oncol

ISSN: 1556-1380

DAY: 6

MONTH: Jun

YEAR: 2007

Current treatment paradigms for locally advanced non-small cell lung cancer. Information

Number of References: 55

LANGUAGE: eng

NlmUniqueID: 101274235

Current treatment paradigms for locally advanced non-small cell lung cancer. Keywords Mesh Terms:

KEYWORDS: Neoplasm Staging

MESH TERMS: therapy

Chemical & Substance for Abstract: Current treatment paradigms for locally advanced non-small cell lung cancer. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for Current treatment paradigms for locally advanced non-small cell lung cancer.

AFFILIATION: Dartmouth Medical School, Lebanon, NH 03756, USA. james.r.rigas@dartmouth.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Thorac Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Current treatment paradigms for locally advanced non-small cell lung cancer Related Publications

• "What will happen if I tell you?" Battered Latina women's experiences of health care.
• A review of bacterial pathogens in Ctenocephalides felis in New Zealand.
• Alpha- and gamma-tocopherol plasma and urinary biokinetics following alpha-tocopherol supplementation.
• Amide-to-E-olefin versus amide-to-ester backbone H-bond perturbations: Evaluating the O-O repulsion for extracting H-bond energies.
• Berkelic acid, a novel spiroketal with selective anticancer activity from an acid mine waste fungal extremophile.
• Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis.
• Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
• Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
• Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model.
• Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity.
• Evaluation of voiding dysfunction and measurement of bladder volume.
• Fatty acid composition of habitual diet.
• Gem protein signaling and regulation.
• Geographical variation in selection, from phenotypes to molecules.
• Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.
• Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.
• Mechanisms of insulin-induced relaxation of the canine proximal stomach after proximal gastric vagotomy.
• Microvascular blood flow dynamics associated with photodynamic therapy, pulsed dye laser irradiation and combined regimens.
• Modeling Shear Damage to Suspended CHO Cells during Cross-Flow Filtration.
• Oxygen cost, walking speed, and perceived exertion in children with cerebral palsy when walking with anterior and posterior walkers.
• Plasma RRR-alpha-tocopherol concentrations are lower in smokers than in non-smokers after ingestion of a similar oral load of this antioxidant vitamin.
• Predictors of aggressive behaviors among rural middle school youth.
• R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
• The interaction between eating disorders and celiac disease: an exploration of 10 cases.
• The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.
• The relationship between pressure flow studies and ultrasound-estimated bladder wall mass.
• Update on Clostridium difficile associated disease.
• Visual response to time-dependent stimuli. I. Amplitude sensitivity measurements.
• emb-4 is a conserved gene required for efficient germline-specific chromatin remodeling during Caenorhabditis elegans embryogenesis.
• gamma-Tocopherol biokinetics and transformation in humans.